Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In cases of obesity and diabetes, the liver is particularly vulnerable to the abnormal uptake and storage of fat. For some individuals, this condition, known as hepatic steatosis, can lead to the development of non-alcoholic steatohepatitis (NASH), which is characterized by liver inflammation and fibrosis. While the exact pathophysiology of NASH remains unclear, it is thought that the gut microbiota-liver axis plays a role in the disease's progression. Given the limited treatment options for…